Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 294-620-0 | CAS number: 91744-56-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Basic data given (comparable to guideline).
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 008
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- no bodyweights determined; individual DPM and individual SI values for each animal are missing; no SI values for the positive control stated
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- no bodyweights determined; individual DPM and individual SI values for each animal are missing; no SI values for the positive control stated
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- no bodyweights determined; individual DPM and individual SI values for each animal are missing; no SI values for the positive control stated
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Succinic acid
- EC Number:
- 203-740-4
- EC Name:
- Succinic acid
- Cas Number:
- 110-15-6
- IUPAC Name:
- succinic acid
- Details on test material:
- - Name of test material (as cited in study report): succinic acid
- Substance type: endogenous substance
- Analytical purity: 99%
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/Ca01aHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS:
- Source: Harlan Winkelmann, Borchen, Germany
- Age at study initiation: 6-12 weeks
- Housing: animals were housed in groups in Macrolon cages on Altromin saw fiber bedding.
- Diet: Altromin 1324 maintenance diet, ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 55 ± 10
- Air changes (per hr): at least 10
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- dimethyl sulphoxide
- Concentration:
- 5, 10 and 25% (w/v)
- No. of animals per dose:
- 5
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: the test substance was soluble in DMSO.
- Irritation: 3 different concentrations were tested to detect the highest tolerable exposure concentration for the main assay. The test substance was applied daily to the ears of 3 animals. Treated animals were observed for systemic effects and local skin irritation, which was assessed by measuring the ear swelling.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: ³H-methyl thymidine incorporation determined by β-scintillation
- Criteria used to consider a positive response: a positive response was obtained, if SI values of treated animals were greater 3 (corresponds to a 3-fold higher ³H-methyl thymidine incorporation than in control animals) and if the data showed a conventional dose response relationship.
TREATMENT PREPARATION AND ADMINISTRATION: each mouse was topically treated with 25 μL of the appropriate formulations of the test substance, the positive control substance (1% (w/v) p-phenylenediamine in DMSO) and the vehicle (DMSO) on the dorsal surface of each ear. Topical applications were repeated once daily on Days 2 and 3. Local irritations were assessed on Day 5 (determination of ear swelling). On the following day, all mice received an intravenous injection of 20 µCi ³H-methyl thymidine. Approximately 5 h later, mice were sacrificed and the draining auricular lymph nodes were excised and weighed (the left and right lymph nodes). The nodes of each individual animal (two lymph nodes per animal) were pooled and collected in Petri dishes containing PBS. A single cell suspension of pooled lymph node cells was prepared by gentle mechanical disaggregation through polyamide gauze (200 mesh size). The gauze was washed with PBS and the cell suspension was pelleted by centrifugation. The supernatants were discarded and the pellets were washed twice with PBS. After washing, each pellet was suspended in approx. 1 mL 5% trichloroacetic acid and incubated at 4 °C overnight for precipitation of macromolecules. Each precipitate was washed again and suspended in 10 mL scintillation fluid, transferred into scintillation vials and stored at room temperature overnight. The ³H-methyl thymidine incorporation was measured in a scintillation counter. - Positive control substance(s):
- other: 1% (w/v) p-phenylenediamine
- Statistics:
- The mean lymph node weights were calculated for each test group. Mean values and standard deviations for the stimulation index (SI) and the lymph node weight index (LNWI) were calculated for each test group. The one-sided Student’s t-test was used to identify statistically significant differences in the mean lymph node weights between treated and control animals.
Results and discussion
- Positive control results:
- No results (SI values) of the positive control group (1% (w/v) p-phenylenediamine) were described in the study.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 1.2
- Test group / Remarks:
- Test Concentration = 5 %
- Remarks on result:
- other: The stimulation index values of the test substance were 1.3, 1.2 and 1.2 at treatment concentrations of 25%, 10% and 5%, respectively. No significant dose-response relationship was observed. Based on the results, EC3 values were not calculated.
- Parameter:
- SI
- Value:
- 1.2
- Test group / Remarks:
- Test Concentration = 10%
- Parameter:
- SI
- Value:
- 1.3
- Test group / Remarks:
- Test Concentration = 25%
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: see Remark
- Remarks:
- Lymph nodes from each individual animal were pooled and DPM values were measured from the pooled lymph node cell suspensions. The measured DPM values per group were corrected by subtracting the background DPM value (DPM values of 5% (w/v) TCA solutions). The individual DPM values for each animal were not presented in this study.
Any other information on results incl. tables
In addition, the lymph node weight index (LNWI) was calculated as the ratio of the arithmetic mean lymph node weight values of the test group and the vehicle control group. No statistically significant increases in the mean LNWI were observed after treatment with 5, 10 and 25% test substance.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- CLP: not classified
DSD: not classified
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.